TY  - CONF

T1  - Afatanib use in non-small cell cancer patients whose tumours have been previously sensitive to EGFR inhibitors: the UK Named Patient Use experience

JO  - LUNG CANCER

PY  - 2013/01/01

AU  - Khan F

AU  - Ottensmeier C

AU  - Popat S

AU  - Danson SJ

ED  - 

DO  - DOI: 10.1016/S0169-5002(13)70030-8

VL  - 79

SP  - S10

EP  - S11

Y2  - 2025/01/03

ER  -